BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7589107)

  • 1. Molecular characterization of human CD94: a type II membrane glycoprotein related to the C-type lectin superfamily.
    Chang C; Rodríguez A; Carretero M; López-Botet M; Phillips JH; Lanier LL
    Eur J Immunol; 1995 Sep; 25(9):2433-7. PubMed ID: 7589107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning of a mouse homolog of CD94 extends the family of C-type lectins on murine natural killer cells.
    Vance RE; Tanamachi DM; Hanke T; Raulet DH
    Eur J Immunol; 1997 Dec; 27(12):3236-41. PubMed ID: 9464811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. cDNA cloning of mouse NKR-P1 and genetic linkage with LY-49. Identification of a natural killer cell gene complex on mouse chromosome 6.
    Yokoyama WM; Ryan JC; Hunter JJ; Smith HR; Stark M; Seaman WE
    J Immunol; 1991 Nov; 147(9):3229-36. PubMed ID: 1680927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization of a gene in the rat homologous to human CD94.
    Dissen E; Berg SF; Westgaard IH; Fossum S
    Eur J Immunol; 1997 Aug; 27(8):2080-6. PubMed ID: 9295048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human NKR-P1A. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes.
    Lanier LL; Chang C; Phillips JH
    J Immunol; 1994 Sep; 153(6):2417-28. PubMed ID: 8077657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence analysis of a 62-kb region overlapping the human KLRC cluster of genes.
    Plougastel B; Trowsdale J
    Genomics; 1998 Apr; 49(2):193-9. PubMed ID: 9598306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A sequence-ready physical map of the region containing the human natural killer gene complex on chromosome 12p12.3-p13.2.
    Renedo M; Arce I; Montgomery K; Roda-Navarro P; Lee E; Kucherlapati R; Fernández-Ruiz E
    Genomics; 2000 Apr; 65(2):129-36. PubMed ID: 10783260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The centromeric part of the human NK gene complex: linkage of LOX-1 and LY49L with the CD94/NKG2 region.
    Bull C; Sobanov Y; Röhrdanz B; O'Brien J; Lehrach H; Hofer E
    Genes Immun; 2000; 1(4):280-7. PubMed ID: 11196705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules.
    Carretero M; Cantoni C; Bellón T; Bottino C; Biassoni R; Rodríguez A; Pérez-Villar JJ; Moretta L; Moretta A; López-Botet M
    Eur J Immunol; 1997 Feb; 27(2):563-7. PubMed ID: 9045931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutting edge: expression of functional CD94/NKG2A inhibitory receptors on fetal NK1.1+Ly-49- cells: a possible mechanism of tolerance during NK cell development.
    Sivakumar PV; Gunturi A; Salcedo M; Schatzle JD; Lai WC; Kurepa Z; Pitcher L; Seaman MS; Lemonnier FA; Bennett M; Forman J; Kumar V
    J Immunol; 1999 Jun; 162(12):6976-80. PubMed ID: 10358137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human gene encoding the lectin-type oxidized LDL receptor (OLR1) is a novel member of the natural killer gene complex with a unique expression profile.
    Yamanaka S; Zhang XY; Miura K; Kim S; Iwao H
    Genomics; 1998 Dec; 54(2):191-9. PubMed ID: 9828121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer cell recognition of HLA class I molecules.
    Brooks AG; Boyington JC; Sun PD
    Rev Immunogenet; 2000; 2(3):433-48. PubMed ID: 11256749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex.
    Pende D; Sivori S; Accame L; Pareti L; Falco M; Geraghty D; Le Bouteiller P; Moretta L; Moretta A
    Eur J Immunol; 1997 Aug; 27(8):1875-80. PubMed ID: 9295021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits.
    Lazetic S; Chang C; Houchins JP; Lanier LL; Phillips JH
    J Immunol; 1996 Dec; 157(11):4741-5. PubMed ID: 8943374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD69-triggered ERK activation and functions are negatively regulated by CD94 / NKG2-A inhibitory receptor.
    Zingoni A; Palmieri G; Morrone S; Carretero M; Lopez-Botel M; Piccoli M; Frati L; Santoni A
    Eur J Immunol; 2000 Feb; 30(2):644-51. PubMed ID: 10671222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells.
    Brooks AG; Borrego F; Posch PE; Patamawenu A; Scorzelli CJ; Ulbrecht M; Weiss EH; Coligan JE
    J Immunol; 1999 Jan; 162(1):305-13. PubMed ID: 9886400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
    Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
    Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic structure and strain-specific expression of the natural killer cell receptor NKR-P1.
    Giorda R; Weisberg EP; Ip TK; Trucco M
    J Immunol; 1992 Sep; 149(6):1957-63. PubMed ID: 1517565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
    Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
    Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cell receptors in cattle: a bovine killer cell immunoglobulin-like receptor multigene family contains members with divergent signaling motifs.
    Storset AK; Slettedal IO; Williams JL; Law A; Dissen E
    Eur J Immunol; 2003 Apr; 33(4):980-90. PubMed ID: 12672064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.